Portolan Capital Management’s SEQUENOM INC NEW SQNM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
Sell
-708,205
Closed -$647K 135
2016
Q2
$647K Sell
708,205
-1,978,099
-74% -$2.36M 0.09% 109
2016
Q1
$3.79M Sell
2,686,304
-1,677,640
-38% -$2.5M 0.51% 70
2015
Q4
$7.16M Sell
4,363,944
-176,837
-4% -$303K 0.91% 34
2015
Q3
$7.95M Sell
4,540,781
-355,453
-7% -$870K 1.05% 35
2015
Q2
$14.9M Buy
4,896,234
+1,429,265
+41% +$5.38M 2.08% 10
2015
Q1
$13.7M Buy
3,466,969
+736,497
+27% +$2.7M 2.51% 5
2014
Q4
$10.1M Buy
2,730,472
+2,040,651
+296% +$6.61M 2.02% 9
2014
Q3
$2.05M Buy
689,821
+37,632
+6% +$138K 0.47% 77
2014
Q2
$2.52M Buy
+652,189
New +$1.91M 0.55% 72

Portolan Capital Management's SQNM Position: Q3 2016 in Review

Portolan Capital Management sold out of SEQUENOM INC NEW (SQNM) in Q3 2016, closing a stake of 708,205 shares — an estimated $647K sold.

Portolan Capital Management first reported a position in SQNM in Q2 2014 and held it in 9 quarters. The position peaked at $14.9M in Q2 2015. 0 funds tracked by Wall St. Rank hold SQNM as of Q3 2016.

  • Portolan Capital Management reported no remaining SEQUENOM INC NEW position as of Q3 2016 after selling out during the quarter.
  • Portolan Capital Management sold 708,205 SEQUENOM INC NEW shares in Q3 2016, an estimated $647K.
  • Portolan Capital Management first reported a position in SEQUENOM INC NEW in Q2 2014 and held it in 9 quarters.
  • Portolan Capital Management's SEQUENOM INC NEW position peaked at $14.9M in Q2 2015.
  • 0 funds tracked by Wall St. Rank held SEQUENOM INC NEW as of Q3 2016.

Based on Portolan Capital Management's 13F filing for Q3 2016, filed 14 Nov 2016.